<DOC>
	<DOC>NCT00318786</DOC>
	<brief_summary>This trial is conducted in Japan. This a clinical trial to study the efficacy and safety of three times a day BIAsp-70 compared to two times a day BIAsp-30 in subjects with type 2 diabetes.</brief_summary>
	<brief_title>Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Subjects with type 2 diabetes Current treatment using intermediateacting, longacting insulin (including longacting insulin analogue) or premixed human insulin for at least 24 weeks HbA1c at least 7.5% and below 10.0% Proliferative retinopathy or maculopathy requiring acute treatment Impaired hepatic and/or renal function Cardiac diseases Uncontrolled hypertension Known hypoglycemia unawareness or recurrent major hypoglycemia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>